DNA 合成市场规模、份额和成长分析（按产品、类型、方法、应用、最终用户和地区）- 产业预测 2025-2032

2023 年 DNA 合成市场规模价值为 45.6 亿美元，预计将从 2024 年的 53.1 亿美元成长到 2032 年的 180.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 16.5%。

受製药、生物技术和基因研究领域的重要应用推动，全球 DNA 合成市场预计将经历显着成长。研究人员和生物技术公司越来越多地使用 DNA 合成服务来创建用于各种应用的 DNA 序列，包括药物开发和基因工程。这种扩张进一步推动了对合成生物学工具的需求不断增长、个人化医疗的进步以及基因编辑的创新。此外，DNA 合成服务有助于快速原型製作和实验，促进创新并加速科学发现。随着生物技术和医疗保健领域的进步，DNA 合成市场将在基因组学和分子生物学的进步中发挥重要作用，塑造这些领域的未来。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

DNA 合成市场规模（依产品/服务划分）及复合年增长率（2025-2032）

• 市场概况
• 装置
• 试剂和耗材
• 服务

DNA 合成市场规模（按类型和复合年增长率） (2025-2032)

• 市场概况
• 寡核苷酸合成
• 基因合成

DNA 合成市场规模（依方法划分）及复合年增长率（2025-2032）

• 市场概况
• 固相合成
• 基于PCR的酶合成
• 基于晶片的合成

DNA 合成市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 诊断
  • 感染疾病
  • 癌症
• 治疗
  • 基因治疗
  • 预防医学
• 研究与开发
  • 克隆和基因编辑
  • 药物研发

DNA 合成市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 製药和生物技术公司
• 合约研究组织 (CRO)
• 合约开发与製造组织 (CDMO)
• 学术研究所

DNA 合成市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（USA）
• Twist Bioscience（USA）
• BIONEER Corporation（South Korea）
• Eton Bioscience, Inc.（USA）
• LGC Biosearch Technologies（UK）
• IBA Lifesciences GmbH（Germany）
• Eurofins Scientific（Luxembourg）
• Integrated DNA Technologies, Inc.（USA）
• Quintara Biosciences（USA）
• GenScript（China）
• Bio Basic Inc.（Canada）
• OriGene Technologies, Inc.（USA）
• Synbio Technologies（USA）
• GeneArt（Germany）
• Genewiz（USA）
• Sangon Biotech（China）
• Creative Biogene（USA）
• BaseClear BV（Netherlands）
• BioCat GmbH（Germany）

结论和建议

DNA Synthesis Market size was valued at USD 4.56 billion in 2023 and is poised to grow from USD 5.31 billion in 2024 to USD 18.03 billion by 2032, growing at a CAGR of 16.5% during the forecast period (2025-2032).

The global DNA synthesis market is poised for substantial growth, driven by its essential applications across pharmaceuticals, biotechnology, and genetics research. Increasingly, researchers and biotech firms are leveraging DNA synthesis services to create tailored DNA sequences for various uses, including drug development and genetic engineering. This expansion is further propelled by the escalating demand for synthetic biology tools, advancements in personalized medicine, and innovations in gene editing. Additionally, DNA synthesis services facilitate rapid prototyping and experimentation, promoting innovation and speeding up scientific discoveries. As the biotechnology and healthcare sectors progress, the DNA synthesis market is set to play a crucial role in advancing genomics and molecular biology, shaping the future of these fields.

Top-down and bottom-up approaches were used to estimate and validate the size of the Dna Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Dna Synthesis Market Segments Analysis

Global DNA Synthesis Market is segmented by Product, Type, Method, Application, End-user and region. Based on Product, the market is segmented into Instruments, Reagents & Consumables and Services. Based on Type, the market is segmented into Oligonucleotide Synthesis and Gene Synthesis. Based on Method, the market is segmented into Solid-phase Synthesis, PCR-based Enzyme Synthesis and Chip-based Synthesis. Based on Application, the market is segmented into Diagnostics, Therapeutics and Research & Development. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Dna Synthesis Market

One of the primary catalysts for growth in the DNA synthesis market is the ongoing progress in genetic engineering technologies. Breakthroughs such as CRISPR-Cas9 and various gene-editing methods have greatly boosted the demand for customized DNA sequences. This heightened need is primarily driven by researchers and biotechnology firms that rely on specific and tailored DNA constructs for their experiments and applications. Consequently, DNA synthesis has become an essential element of innovative genetic engineering initiatives, facilitating the advancement of research and applications in diverse fields, including medicine, agriculture, and industrial biotechnology. This trend underscores the pivotal role of DNA synthesis in scientific advancement.

Restraints in the Dna Synthesis Market

A significant challenge facing the DNA synthesis market is the stringent regulatory framework governing the synthesis and application of genetic materials. Regulations and oversight, especially related to gene editing and biotechnology, can hinder market access and impede research and development initiatives. While these regulations are crucial for ensuring ethical practices and safety, they can create obstacles for companies operating within this sector. The necessity to comply with complex legal requirements can slow innovation and make it difficult for businesses to navigate the evolving landscape of DNA technology, ultimately impacting their competitiveness and growth prospects.

Market Trends of the Dna Synthesis Market

The DNA synthesis market is experiencing notable growth driven by advancements in gene editing technologies, particularly CRISPR-Cas9. These innovations are significantly enhancing the precision of genetic modifications across various sectors, including therapeutics, agriculture, and synthetic biology. As the demand for custom DNA sequences escalates, fueled by the increasing accessibility and versatility of gene editing tools, the market is set to expand further. Companies in the biotech and pharmaceutical industries are seeking tailored DNA solutions to advance research and product development, making the DNA synthesis market a dynamic landscape poised for sustained evolution and investment opportunities.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global DNA Synthesis Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Consumables
• Services

Global DNA Synthesis Market Size by Type & CAGR (2025-2032)

• Market Overview
• Oligonucleotide Synthesis
• Gene Synthesis

Global DNA Synthesis Market Size by Method & CAGR (2025-2032)

• Market Overview
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis

Global DNA Synthesis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
  • Infectious Diseases
  • Cancer
• Therapeutics
  • Gene Therapy
  • Preventive Medicine
• Research & Development
  • Cloning and Gene Editing
  • Drug Discovery & Development

Global DNA Synthesis Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Academic & Research Institutes

Global DNA Synthesis Market Size & CAGR (2025-2032)

• North America (Product & Service, Type, Method, Application, End-user)
  • US
  • Canada
• Europe (Product & Service, Type, Method, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type, Method, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type, Method, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type, Method, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIONEER Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eton Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA Lifesciences GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quintara Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Basic Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneArt (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangon Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BaseClear B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations